Gene therapy company cuts 78 jobs as it jump-starts program in blinding eye disease


The job cuts will save the company more than $15 million annually, it said, with upfront restructuring costs of $4.2 million.

Previous Net Health expands predictive analytics resources
Next Blue Bottle Coffee CEO Karl Strovink wants to make your daily cup an experience